Additionally, activated HSCs can contribute to tumor development by secretion of cytokines and growth factors (including TGFβ, PDGF, and VEGF) inducing angiogenesis, reduced immune surveillance, and tumor progression [2, 53] (Fig. 1). This evidence concerns the gene VEGFA and neoplasm.